- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Top U.K. Drug Adviser Out
30 October 2009 2:22 pm
Illicit drugs, science and politics can be a volatile mix, no doubt. So it's not a total surprise that David Nutt, a respected psychopharmacologist at the Bristol outpost of Imperial College London, was canned today as the U.K. top drug advisor. His downfall was a paper in which Nutt argued that ecstasy and other drugs caused less harm than alcohol, although the researcher had clashed before with the government's drug policies.
Phil Willis, Chairman of the House of Commons science and technology committee, has already released a statement noting he asked the Home Secretary "for clarification as to why the distinguished scientist Sir David Nutt has been removed of duties as Chair of Advisory Council on Misuse of Drugs (ACMD) at a time when independent scientific advice to government is essential. It is disturbing if an independent scientist should be removed for reporting sound scientific advice."